Erratum: Lentiviral siRNAs targeting multiple highly conserved RNA sequences of human immunodeficiency virus type 1 (Gene Therapy (2005) vol. 12 (1133-1144) 10.1038/sj.gt.3302509);Lentiviral siRNAs targeting multiple highly conserved RNA sequences of human immunodeficiency virus type 1

Gene Therapy

Volumn 12, Issue 14, 2005, Pages 1133-1144

  Chang, L J ^a   Liu, X ^a   He, J ^a  

^a UNIVERSITY OF FLORIDA   (United States)

Author keywords

HIV 1; Lentiviral vectors; siRNA

Indexed keywords

GAG PROTEIN; LENTIVIRUS VECTOR; NEF PROTEIN; POL PROTEIN; SMALL INTERFERING RNA; VIRUS PROTEIN; VIRUS RNA; VPU PROTEIN;

ARTICLE; CELL PROTECTION; CONTROLLED STUDY; CYTOTOXICITY; DOWN REGULATION; GENE CASSETTE; GENE CONSTRUCT; GENE DELETION; GENE TARGETING; GENETIC CONSERVATION; GENETIC TRANSDUCTION; HOST CELL; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; KINETICS; LYMPHOMA CELL LINE; MACROPHAGE; MOLECULAR CLONING; NONHUMAN; NORTHERN BLOTTING; PERIPHERAL LYMPHOCYTE; PRIORITY JOURNAL; RNA SEQUENCE; STATISTICAL SIGNIFICANCE; SYNCYTIUM; T LYMPHOCYTE; VIRAL GENE DELIVERY SYSTEM; VIRUS GENOME; VIRUS INACTIVATION; VIRUS INHIBITION; VIRUS RECOMBINANT; VIRUS REPLICATION; VIRUS STRAIN;

HIV TYPE 1; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 22744451729     PISSN: 09697128     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.gt.3302542     Document Type: Erratum

References (36)

1. Pantaleo G, Fauci AS. Immunopathogenesis of HIV infection. Annu Rev Microbiol 1996; 50: 825-854.
2. Verma IM, Somia N. Gene therapy - promises, problems and prospects. Nature 1997; 389: 239-242.
3. Buchschacher Jr GL, Wong-Staal F. Development of lentiviral vectors for gene therapy for human diseases. Blood 2000; 95: 2499-2504.
4. Chang L-J, Gay EE. The molecular genetics of lentiviral vectors - current and future perspectives. Curr Gene Ther 2001; 1: 237-251.
5. Plasterk RH. RNA silencing: the genome's immune system. Science 2002; 296: 1263-1265.
6. Akkina R et al.. siRNAs, ribozymes and RNA decoys in modeling stem cell-based gene therapy for HIV/AIDS. Anticancer Res 2003; 23: 1997-2005.
7. Elbashir SM et al. Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature 2001; 411: 494-498.
8. Dillin A. The specifics of small interfering RNA specificity. Proc Natl Acad Sci USA 2003; 100: 6289-6291.
9. Qin X-F, An DS, Chen ISY, Baltimore D. Inhibition of HIV-1 infection in human T cells by lentiviral-mediated delivery of small interfering RNA against CCR5. Proc Natl Acad Sci USA 2002; 100: 183-188.
10. Butticaz C et al. Protection from HIV-1 infection of primary CD4T cells by CCR5 silencing is effective for the full spectrum of CCR5 expression. Antivir Ther 2003; 8: 373-377.
11. Anderson J, Banerjea A, Planelles V, Akkina R. Potent suppression of HIV type 1 infection by a short hairpin anti-CXCR4 siRNA. AIDS Res Hum Retroviruses 2003; 19: 699-706.
12. Ji J, Wernli M, Klimkait T, Erb P. Enhanced gene silencing by the application of multiple specific small interfering RNAs. FEBS Lett 2003; 552: 247-252.
13. Li MJ et al. Inhibition of HIV-1 infection by lentiviral vectors expressing Pol III-promoted anti-HIV RNAs. Mol Ther 2003; 8: 196-206.
14. Lee MT, Coburn GA, McClure MO, Cullen BR. Inhibition of human immunodeficiency virus type 1 replication in primary macrophages by using Tat- or CCR5-specific small interfering RNAs expressed from a lentivirus vector. J Virol 2003; 77: 11964-11972.
15. Capodici J, Kariko K, Weissman D. Inhibition of HIV-1 infection by small interfering RNA-mediated RNA interference. J Immunol 2002; 169: 5196-5201.
16. Lee NS et al. Expression of small interfering RNAs targeted against HIV-1 rev transcripts in human cells. Nat Biotechnol 2002; 20: 500-505.
17. Banerjea A et al. Inhibition of HIV-1 by lentiviral vector-transduced siRNAs in T lymphocytes differentiated in SCID-hu mice and CD34+ progenitor cell-derived macrophages. Mol Ther 2003; 8: 62-71.
18. Boden D et al. Promoter choice affects the potency of HIV-1 specific RNA interference. Nucleic Acids Res 2003; 31: 5033-5038.
19. Park WS, Hayafune M, Miyano-Kurosaki N, Takaku H. Specific HIV-1 env gene silencing by small interfering RNAs in human peripheral blood mononuclear cells. Gene Therapy 2003; 10: 2046-2050.
20. McManus MT, Sharp PA. Gene silencing in mammals by small interfering RNAs. Nat Rev Genet 2002; 3: 737-747.
21. Dykxhoorn DM, Novina CD, Sharp PA. Killing the messenger: short RNAs that silence gene expression. Nat Rev Mol Cell Biol 2003; 4: 457-467.
22. Tiscornia G, Singer O, Ikawa M, Verma IM. A general method for gene knockdown in mice by using lentiviral vectors expressing small interfering RNA. Proc Natl Acad Sci USA 2003; 100: 1844-1848.
23. Rubinson DA et al. A lentivirus-based system to functionally silence genes in primary mammalian cells, stem cells and transgenic mice by RNA interference. Nat Genet 2003; 33: 401-406.
24. Boden D et al. Human immunodeficiency virus type 1 escape from RNA interference. J Virol 2003; 77: 11531-11535.
25. Reynolds A et al. Rational siRNA design for RNA interference. Nat Biotechnol 2004; 22: 326-330.
26. Chang L-J, Zaiss A-K. Methods for the preparation and use of lentivirus vectors. In: Morgan J (ed). Gene Therapy Protocols. Humana Press Inc.: Totowa, NJ, 2001, pp 303-318.
27. Dernburg AF, Karpen GH. A chromosome RNAissance. Cell 2002; 111: 159-162.
28. Bailis JM, Forsburg SL. RNAi hushes heterochromatin. Genome Biol 2002; 3: S1035 (Review).
29. Zeng Y, Cullen BR. RNA interference in human cells is restricted to the cytoplasm. RNA 2002; 8: 855-860.
30. Schramke V, Allshire R. Hairpin RNAs and retrotransposon LTRs effect RNAi and chromatin-based gene silencing. Science 2003; 301: 1069-1074.
31. Volpe TA et al. Regulation of heterochromatic silencing and histone H3 lysine-9 methylation by RNAi. Science 2002; 297: 1833-1837.
32. Sijen T, Plasterk RH. Transposon silencing in the Caenorhabditis elegans germ line by natural RNAi. Nature 2003; 426: 310-314.
33. Chang L-J, Zhang C. Infection and replication of Tat-minus human immunodeficiency viruses: genetic analyses of LTR and tat mutants in primary and long-term human lymphoid cells. Virology 1995; 211: 157-169.
34. Tremblay M et al. New CD4(+) cell line susceptible to infection by HIV-1. J Med Virol 1989; 28: 243-249.
35. Zaiss A-K, Son S, Chang L-J. RNA 3′-readthrough of oncoretrovirus and lentivirus: implications in vector safety and efficacy. J Virol 2002; 76: 7209-7219.
36. Kimpton J, Emerman M. Detection of replication-competent and pseudotyped human immunodeficiency virus with a sensitive cell line on the basis of activation of an integrated beta-galactosidase gene. J Virol 1992; 66: 2232-2239.